pilot for end-to-end testing of compliance with administrative simplification
Post on 26-Feb-2016
39 Views
Preview:
DESCRIPTION
TRANSCRIPT
Pilot for End-to-End Testing of Compliance with Administrative Simplification
Presented by: National Government Services, Inc.April 18, 201310:30 AM – 11:30 AM, EST
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
2
If you are having difficulty viewing the presentation, try changing the monitor resolution to 1280 x 1024 size.To download the draft versions of the checklists, visit the CMS End-to-End Testing web page at http://www.cms.gov/Regulations-and-Guidance/HIPAA-Administrative-Simplification/Affordable-Care-Act/End-to-End-Testing.html.
Welcome Industry Collaborative Partners
Presenters: Julie McBee, BA/POEDavid Carrier, Lead BADean Cook, Advisor/SME
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Agenda
Welcome and attendanceOpening remarksDefinitionsFrom the mailboxBallot questions and commentsNoblis/Ketchum/NGS content comparisonApril 4 Session Homework Review
– Transaction vs. Process Flows– Open Discussion
April 18 Session Homework Assignment– Test Scenarios
Questions Closing remarks
3
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Opening remarks
4
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Industry Collaborative Partners (ICPs)
Aetna* American Health Insurance Plans (AHIP)* American Hospital Association (AHA) American Medical Association (AMA) CMS Medicaid CMS Medicare Fee For Service Emdeon Healthcare Billing & Management Association (HBMA) IVANS Medicaid – CSG Government Solutions Medical Group Management Association (MGMA) Nachimson Advisors, LLC Providence Health and Services TIBCO Foresight TRICARE UNC Health Care Walgreens WellPoint Veteran’s Affairs* One partner; two divisions
5
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Ground rules
6
All participants will be muted upon log in for the start of the webinar. Once the opening presentation is done, we will open it up for questions. Please provide your name when asking a question so that we know who is
speaking. Additionally, we ask that only the primary and back-up points of contact be
your designated speakers on the webinar. With the number of participants we expect to participate on our webinars, we want to give each Industry Leader ample time to contribute.
All participants are asked to listen to and value all contributions equally. We are trying to make sure this is a collaborative effort where all industry voices can be heard.
We value your time so please keep your discussion focused. We will be opening the call for each contributor to speak for up to 3 minutes.
We will let you know when you are at 2 and 2:30 minutes to allow you to finalize your comments.
Silence equals agreement.
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Goals
The goals of the pilot are:
To develop and implement a process and methodology for end-to-end testing of the transaction standards, operating rules, code sets, identifiers, and other Administrative Simplification requirements based on industry feedback and participation.
To develop an industry-wide “Best Practice” for end-to-end testing that lays the ground work for a more efficient and less time consuming method for health care industry testing of future standards, leading to more rapid adoption of the future standards.
7
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Intended outcomes
The intended outcome of the pilot is:
To provide documents and artifacts to all industry segments outlining the critical check-points needed to ensure compliance with the current and future mandates
To provide a universal testing process and methodology that can be adopted by all industry segments
To provide a framework and common understanding around the end-to-end testing process and definitions
8
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Pilot overview
Phase I – Business and Gap Analysis started on September 24, 2012, and ran through December 21, 2012. Complete.
Phase II - Development of Pilot Testing started on December 10, 2012, and will run through June 27, 2013 (approximately six months)*
Phase III - The planned start date for Phase III, Implementation and Quality Assurance, is July 1, 2013, and will run through September 23, 2013 (approximately three months)*
*Actual dates are subject to change during detailed schedule development.
9
We are here.
Proprietary and Confidential 10
ngs.compliancetesting@wellpoint.com
Definitions
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Definitions
11
It was requested that we provide a definition of “covered entity” on the Definitions tab of the checklists. This is the definition we created. It will be added to the Definitions tab of all the checklists.
Covered entity
While every organization may not be deemed a covered entity per the Administrative Simplification standards, we highly recommend participants consider using this checklist as a guide in assisting their organization through the process of end-to-end testing in order to meet the end date of regulation changes and aiding in keeping system(s) current.
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
12
Definitions
Comments 4/18/2013– .
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
From the mailbox
13
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
14
From the mailbox
These are comments from the most recent survey. For all checklists:
– On Initial Assessment Tab - A critical question is missing regarding: Has this business completed implementation of ACA-mandated HIPAA CAQH CORE Operating Rules Version X.X.X for HIPAA transactions? The URL for obtaining these operating rules is www.caqh.org. This information has been added to the Initial Assessment tab.
– On Administrative Simplification Tab - Missing key/critical task re obtaining updated publications and tools such as the CAQH CORE Operating Rules Gap Analysis and Planning Tool. The URLs for obtaining these tools are http://www.caqh.org/ORMandate_Eligibility.php and http://www.caqh.org/ORMandate_EFT.php. This information has been added to the Administrative Simplification tab.
– On ACA Tab - Missing reference to the required CAQH CORE infrastructure rules, such as connectivity, response time, system availability. This information has been added to the Administrative Simplification tab which now combines ACA and Administrative Simplification.
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
15
From the mailbox
This information is actually from the most recent survey. Huge program affecting multiple areas; concerned about payers readiness. Put more ownership on all parties to meet regulations, concerned if payers
don't update how will that affect our Providers revenue? Some direction on who should drive the bus for the full E2E. For example, if
Health Plans must be the entity to certify to CMS that they are compliant, should they be driving the E2E integration testing process once the individual pieces (vendors, payers, providers) are ready?
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
16
From the mailbox
Comments 4/18/2013– .
Proprietary and Confidential 17
ngs.compliancetesting@wellpoint.com
Ballot questions and comments
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
18
Ballot questions and comments
Emdeon approves these checklists as comprehensive and generally representative of key testing activities. However, we do not feel the Level 2 and Level 3 checklist activities can be scaled to support the volume of Trading Partners for an organization like Emdeon. Our pilot needs a bit more clarification on what changes you think need to be added or deleted.
A minor comment would be to add a definition of “Covered Entities” and “Trading Partners” in the front section. A covered entity is explained in G.1 in the small physician spreadsheet, but an overall definition in the Definitions section would be helpful those not familiar. “Covered entity” has been added to the Initial Assessment, Lessons Learned/Notes section and to the Definitions tab. Will add to Definitions if it benefits users.
Another suggestion is to consider providing a visual map of critical steps to make these steps seem less tedious, especially for the smaller practice. After viewing the visual flows, is there still a flow needed?
If helpful, the various URLs to AMA’s ICD-10 materials is www.ama-assn.org/go/icd-10 and 5010 resources is www.ama-assn.org/go/5010 . Will add links where applicable.
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
19
Ballot questions and comments
I have reviewed the “vendor-to-payer” detailed spreadsheet and have a considerable number of concerns. First, the “covered entity” checklist is confusing. Even if the vendor is not a covered entity, they should be looking at how up to date they are. We are adding Lessons Learned/Notes entry on Initial Assessment to explain “covered entity” and recommend using the checklist for tracking whether covered or not.
Looking at Task 3.6 under Level 2, I don’t see how we expect vendors to complete a minimum of two cycles with “each” trading partner. A representative sample should suffice. Adding consistent and standard verbiage to state that it is with the determined mission-critical trading partners on all checklists in all areas where applicable.
Microsoft Excel Worksheet
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
20
Ballot questions and comments
Comments 4/18/2013– .
Proprietary and Confidential 21
ngs.compliancetesting@wellpoint.com
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
22
CMS requested that NGS review the various ICD-10 materials produced and distributed by Noblis/Ketchum to locate consistencies and inconsistencies. In the case of inconsistencies, NGS was requested to address its findings.
NGS has only one recommendation for the Noblis/Ketchum materials. The definitions of “levels” in their documents do not align with those on the NGS checklists, especially “Level 3”. NGS recommends that Noblis/Ketchum update their documents to include the “Level 3” definition.
Small/Medium Provider Noblis/Ketchum include project management and project plan development information
in their implementation guide. NGS is not developing or instructing development of a project management plan or template.
Noblis/Ketchum include a list of the types of providers impacted by ICD-10. NGS does not include such a list, but lists those that constitute small and medium providers who should employ the checklists.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
23
Small/Medium Provider (continued) Noblis/Ketchum explain about using the 5010 format. NGS includes item in the Initial
Assessment about 5010 compliance. NGS will update checklists to include the ICD-10 implementation date in conjunction with 5010 compliance on all checklists.
Noblis/Ketchum compare the ICD-9 format to the ICD-10 format. NGS does not provide this information, but links to websites are provided where this information is available.
Noblis/Ketchum defines small physician as 1 – 5 physicians, single specialty or multi-specialty, but does not mention staff numbers. NGS defines similarly.
Noblis/Ketchum defines medium practice as 6 to 20. NGS will alter from 6 to 24 to 6 to 25.
Noblis/Ketchum timelines are more refined and defined. NGS timelines are guidelines and not intended to be a building block for a project plan.
Noblis/Ketchum includes timeline entry for training of coders. NGS includes a Task (2.2) about training and links to associations like AAPC (Task 1.2).
Noblis/Ketchum includes development of a Communication Plan. NGS will add this task to all of the High Level Checklists. It is already listed as one of the plans to be developed in the detailed checklists.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
24
Small/Medium Provider (continued) Noblis/Ketchum materials contain information that would serve the users of the
checklists for development of communication, training, and risk management plans. NGS will add links to the appropriate Noblis/Ketchum materials on all detailed checklists.
Noblis/Ketchum implementation guides include definitions for the various types of testing. NGS will add links to the Noblis/Ketchum implementation guides rather than the Wikipedia links already included in the NGS checklists.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
25
Large Provider The Noblis/Ketchum implementation guide includes historical and implementation
information about ICD-9 and ICD-10. NGS includes links to various websites where such information can be obtained.
Noblis/Ketchum include a list of the types of providers impacted by ICD-10. NGS does not include such a list, but lists those that constitute large providers who should employ the checklists.
Noblis/Ketchum defines large practice as 25 or more physicians. NGS defines similarly. Noblis/Ketchum timelines are more refined and defined. NGS timelines are guidelines and
not intended to be a building block for a project plan. Noblis/Ketchum phases do not match NGS Elements completely. Noblis/Ketchum has
Communication and Awareness, Assessment, Operational Implementation, Testing, and Transition. NGS usesPlanning, Assessment, Design, Development, Testing, and Transition.
Noblis/Ketchum materials contain information that would serve the users of the checklists for development of communication, training, and risk management plans. NGS will add links to the appropriate Noblis/Ketchum materials on all detailed checklists.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
26
Payer The Noblis/Ketchum implementation guide includes historical and implementation
information about ICD-9 and ICD-10. NGS includes links to various websites where such information can be obtained.
Noblis/Ketchum timelines are more refined and defined. NGS timelines are guidelines and not intended to be a building block for a project plan.
Noblis/Ketchum materials contain information that would serve the users of the checklists for development of communication, training, and risk management plans. NGS will add links to the appropriate Noblis/Ketchum materials on all detailed checklists.
Noblis/Ketchum implementation guide goes into detail about ICD-10 clinical documentation. NGS checklists have tasks to identify impact to business processes and provides links to the CMS ICD-10 web page.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
27
Vendor Only timeline and checklist materials are available from Noblis/Ketchum for vendors.
However, NGS offers links to websites for information about ICD-10 from other sources such as CMS, other agencies, and national associations.
Noblis/Ketchum timelines are more refined and defined. NGS timelines are guidelines and not intended to be a building block for a project plan.
Noblis/Ketchum materials contain information that would serve the users of the checklists for development of communication, training, and risk management plans. NGS will add links to the appropriate Noblis/Ketchum materials on all detailed checklists.
Noblis/Ketchum/NGS content comparison
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
28
Noblis/Ketchum/NGS content comparison
Comments 4/18/2013– .
Proprietary and Confidential 29
ngs.compliancetesting@wellpoint.com
April 4 session homework review
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Transaction versus process flows
30
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Transaction versus process flows
31
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
32
Comments 4/18/2013
– .
Transaction versus process flows
Proprietary and Confidential 33
ngs.compliancetesting@wellpoint.com
April 18 session homework assignment
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
34
The test scenarios will be added to the detailed checklists as a fifth tab.
The test scenarios tab information will be emailed to you for your review. We will discuss it during the April 25 session.
If you have questions or comments prior to the April 25 session, send them to the ngs.compliancetesting@wellpoint.com mailbox.
Test scenarios
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Questions?
35
Proprietary and Confidential 36
ngs.compliancetesting@wellpoint.com
Closing remarks
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Upcoming webinars
37
The Listening Session webinars are open to everyone who wants to attend. To request an invitation, the attendee must send contact information to the
ngs.complaincetesting@wellpoint.com mailbox. Each session is limited to 100 participants. As sessions fill up, additional sessions will be offered. Complete schedule for May Listening Sessions coming soon!
.
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Upcoming webinars
38
.
Schedule for Listening Session Webinars
Date Time Topic
Thursday, April 18 2– 3 PM, EST, or as published
Vendor-to-Provider End-to-End Testing Checklists and Documents
Tuesday, April 23 Vendor-to-Payer End-to-End Testing Checklists and Documents
Wednesday, April 24 Vendor-to-Provider End-to-End Testing Checklists and Documents – Cooperative Exchange
Thursday, April 25 Large Provider End-to-End Testing Checklists and Documents #1
Tuesday, April 30 Small Provider End-to-End Testing Checklists and Documents #1
Wednesday, May 1 Payer End-to-End Testing Checklists and Documents #2
Thursday, May 2 Small Provider End-to-End Testing Checklists and Documents – Tribal Affairs Group
Tuesday, May 7 Small Provider End-to-End Testing Checklists and Documents #2
Wednesday, May 8 Large Provider End-to-End Testing Checklists and Documents #2
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Upcoming webinars
39
The ICP webinars continue through April. Complete schedule for May ICP webinars coming soon!
.
Schedule for Listening Session WebinarsDate Time Topic
Thursday, April 25 10:30 – 11:30 AM, EST Test scenarios
Proprietary and Confidential
More information
40
Listening Sessions
To register for continuing Listening Sessions, send us an email with your contact information to ngs.compliancetesting@wellpoint.com.
CMS ICD-10 web page located at http://www.cms.gov/Medicare/Coding/ICD10/
CMS End-to-End Testing web page located at http://www.cms.gov/Regulations-and-Guidance/HIPAA-Administrative-Simplification/Affordable-Care-Act/End-to-End-Testing.html has links to all the checklists.
NGS WEDI End-to-End Testing Checklist presentations are available at http://www.wedi.org/forms/meeting/MeetingFormPublic/view?id=220AC00000156
Proprietary and Confidential ngs.compliancetesting@wellpoint.com
Contact us
Send questions to ngs.compliancetesting@wellpoint.com– Our goal is to acknowledge all emails within one business day
Additional contact resources . . .
41
Resource name Role E-mail addresses Work phone Cell phone
David Carrier Lead BA David.Carrier@WellPoint.com (207) 253-1203 (207) 210-2340
Dean Cook Advisor/SME Dean.Cook@WellPoint.com (502) 889-4762 (502) 376-6510
Julie McBee BA/POE Julie.McBee@WellPoint.com (317) 595-4908 (317) 586-0021
top related